Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Curr Mol Med. 2013 Dec;13(10):1523–1537. doi: 10.2174/1566524013666131111120951

Fig. (1).

Fig. (1)

Radioimmunoscintigraphy (RIS) of HER-2-positive SKOV-3 tumor-bearing mice with 99mTc-labeled ZHER-2:342 affibody. (A) At 1 h and 2 h post-injection (pi), tumors were visualized on the right hind legs. (B) A better image contrast was obtained at 5 h pi. As a negative control, a pre-injected dose of excess unlabeled affibody blocked tracer uptake in the tumor. Adapted from [55].